{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-016559","form_type":"8-K","ticker":"ATNM","cik":"0001388320","company_name":"Actinium Pharmaceuticals, Inc.","filed_at":"2026-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.965161+00:00","generated_at":"2026-05-16T02:44:54.808494+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Actinium CFO Steve O'Loughlin resigns; CEO Sandesh Seth named principal financial officer","bullets":["Steve O'Loughlin resigns as CFO effective Feb 27, 2026 to pursue other opportunities.","No disagreements with the company contributed to his resignation.","Board appoints CEO/Chairman Sandesh Seth as principal financial officer effective same date.","Sandesh Seth has 25+ years in pharma, investment banking, and equity research."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-016559","json":"https://secwatch.observer/filing/0001213900-26-016559.json","markdown":"https://secwatch.observer/filing/0001213900-26-016559.md","text":"https://secwatch.observer/filing/0001213900-26-016559.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026016559/0001213900-26-016559-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026016559/ea0277127-8k_actinium.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:44:54.808494+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}